Old World Cutaneous Leishmaniasis and Refugee Crises in the Middle East and North Africa

PLoS Neglected Tropical Diseases

Volumn 10, Issue 5, 2016, Pages

  Du, Rebecca ^a   Hotez, Peter J ^a,b,c   Al Salem, Waleed S ^d   Acosta Serrano, Alvaro ^d  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b BAYLOR UNIVERSITY   (United States)

^c RICE UNIVERSITY   (United States)

^d LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MEGLUMINE ANTIMONATE; STIBOGLUCONATE SODIUM;

DISEASE TRANSMISSION; EDITORIAL; HEALTH CARE; HUMAN; LEISHMANIA; NONHUMAN; NORTH AFRICA; REFUGEE; SKIN LEISHMANIASIS; SYRIAN ARAB REPUBLIC; TROPICAL DISEASE; WAR; WASTE MANAGEMENT; WORLD HEALTH ORGANIZATION; AFRICA; ENDEMIC DISEASE; ETHNOLOGY; LEISHMANIASIS, CUTANEOUS; LIBYAN ARAB JAMAHIRIYA; NEGLECTED DISEASES; PARASITOLOGY; WARFARE; YEMEN;

AFRICA; ENDEMIC DISEASES; HUMANS; LEISHMANIASIS, CUTANEOUS; LIBYA; NEGLECTED DISEASES; REFUGEES; SYRIA; WARFARE; YEMEN;

EID: 84971619697     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0004545     Document Type: Editorial

References (75)

1. Ashford RW, Rioux J-A, Jalouk L, Khiami A, Dye C, Evidence for a long-term increase in the incidence of Leishmania tropica in Aleppo, Syria. Trans R Soc Trop Med Hyg. 1992;87(3):247–9.
2. Hayani K, Dandashli A, Weishaar E, Cutaneous Leishmaniasis in Syria: Clinical Features, Current Status and the Effects of War. Acta Derm Venereol. 2015;95:62–6. doi: 10.2340/00015555-198825342106
3. Kallel K, Haouas N, Pratlong F, Kaouech E, Belhadj S, Anane S, et al. Cutaneous leishmaniasis caused by Leishmania infantum MON-24 in Tunisia: extension of the focus to the center of the country. Bull Soc Pathol Exot. 1990. 2008;101(1):29–31.
4. Jacobson R, Leishmaniasis in an era of conflict in the Middle East. Vector Borne Zoonotic Dis. 2011;11:247–58. doi: 10.1089/vbz.2010.006820846030
5. Aoun K, Bouratbine A, Cutaneous Leishmaniasis in North Africa: a review. Parasite. 2014Mar14;21(14).
6. Pratlong F, Dereure J, Ravel C, Lami P, Balard Y, Serres G, et al. Geographical distribution and epidemiological features of Old World cutaneous leishmaniasis foci, based on the isoenzyme analysis of 1048 strains. Trop Med Int. 2009Sep;14(9):10711085.
7. Hotez P, Savioli L, Fenwick A, Neglected Tropical Diseases of the Middle East and North Africa: Review of Their Prevalence, Distribution, and Opportunities for Control. PLoS Negl Trop Dis. 2012Feb28;
8. TDR. Disease Watch Focus: Leishmaniasis. Nat Rev Microbiol (Internet). http://www.who.int/tdr/publications/disease_watch/leish/en/#
9. Murray CJ, Barber RM, Foreman KJ, Ozgoren AA, Abd-Allah F, et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition. The Lancet. 2015Aug28;
10. Bern C, Maguire JH, Alvar J, Complexities of Assessing the Disease Burden Attributable to Leishmaniasis. PLoS Negl Trop Dis. 2008;2(10):e313. doi: 10.1371/journal.pntd.000031318958165
11. Reithinger R, Dujardin J, Louzir H, Pirmez C, Alexander B, Brooker S, Cutaneous Leishmaniasis. Lancet Infect Dis. 2007;7(9):581–96. 17714672
12. Yanik M, Gurei M, Simsek Z, Kati M, The psychological impact of cutaneous leishmaniasis. Clin Exp Dermatol. 2004;29(5):464–7. 15347324
13. Kassi M, Kassi M, Afghan AK, Rehman R, Kasi PM, Marring Leishmaniasis: The Stigmatization and the Impact of Cutaneous Leishmaniasis in Pakistan and Afghanistan. PLoS Negl Trop Dis. 2008;2(10):e259. doi: 10.1371/journal.pntd.000025918958168
14. Alvar J, Yactayo S, Bern C, Leishmaniasis and poverty. Trends Parasitol. 2006Oct4;22(12):552–7. 17023215
15. WHO. Neglected Tropical Diseases (Internet). http://www.who.int/neglected_diseases/diseases/en/
16. Al-Salema W, Subramaniama K, Hainesa LR, Kelly-Hopee L, Pigottd D, Hayd SI, et al. Cutaneous Leishmaniasis and the Conflict in Syria: Re-emergence of a Tropical Disease Threat.
17. EMRO. Cutaneous Leishmaniasis in the Syrian Arab Republic (Internet). World Health Organization: Regional Office for the Eastern Mediterranean. http://www.emro.who.int/neglected-tropical-diseases/countries/cl-syria.html
18. Tayeh A, Jalouk L, Cairncross S, Twenty years of cutaneous leishmaniasis in Aleppo, Syria. Trans R Soc Trop Med Hyg. 1997;91(6):657–9. 9509171
19. Amirahmadi H, Urban Development in the Muslim World. New Brunswick and London: Transaction Publishers; 2012.
20. Salam N, Mohammed W, Azzi A, Leishmaniasis in the Middle East: Incidence and Epidemiology. PLoS Negl Trop Dis. 2014Oct2;8(10).
21. Cousins S, Experts sound alarm as Syrian crisis fuels spread of tuberculosis. BMJ. 2014;7397.
22. Hotez PJ, Vaccine Science Diplomacy: Expanding Capacity to Prevent Emerging and Neglected Tropical Diseases Arising from Islamic State (IS)- Held Territories. PLoS Negl Trop Dis. 2015Sep24;9(9):e0003852. doi: 10.1371/journal.pntd.000385226402466
23. Inci R, Ozturk P, Mulayim MK, Ozyurt K, Alatas ET, Inci MF, Effect of the Syrian Civil War on Prevalence of Cutaneous Leishmaniasis in Southeastern Anatolia, Turkey. Med Sci Monit. 2015;21:2100–4. doi: 10.12659/MSM.89397726190279
24. Seaman J, Mercer A, Sondorp E, The epidemic of visceral leishmaniasis in western Upper Nile, southern Sudan: course and impact from 1984 to 1994. Int J Epidemiol. 1996;25(4):862–671. 8921468
25. Bompangue D, Giraudoux P, Piarroux M, Mutambo G, Shamavu R, Sudre B, et al. Cholera epidemics, war and disasters around Goma and Lake Kivu: an eight-year survey. PLoS Negl Trop Dis. 2009;3(5):e346.
26. Beyrer C, Villar J, Suwanvanchkij V, Singh S, Baral S, Mills E, Neglected diseases, civil conflicts, and the right to health. Lancet. 2007Aug18;370(9587):619–27. 17707757
27. Bausch D, Schwarz L, Outbreak of ebola virus disease in Guinea: where ecology meets economy. PLoS Negl Trop Dis. 2014Jul31;8(7):e3056. doi: 10.1371/journal.pntd.000305625079231
28. Cousins S, Syrian crisis: health experts say more can be done. The Lancet. 2015;385(9972):931–4.
29. 2015 UNHCR country operations profile- Syrian Arab Republic (Internet). UNHCR. http://www.unhcr.org/pages/49e486a76.html
30. Sharara S, Kanj SS, War and Infectious Diseases: Challenges of the Syrian Civil War. PLoS Pathog. 2014Nov;10(11):e1004438.
31. UNHCR. Syria Regional Refugee Response: Inter-agency Information Sharing Portal. UNHCR; 2015 Oct.
32. Doocy S, Delbiso TD, Guha-Sapir D, The Humanitarian Situation in Syria: A Snapshort in the Third Year of the Crisis. PloS Curr Disasters. 2015Mar3;
33. Saroufim M, Charafeddine K, Issa G, Haifaa K, Habib R, Berry A, et al. Ongoing Epidemic of Cutaneous Leishmaniasis among Syrian Refugees, Lebanon. Emerg Infect Dis. 2014;20(10):1712–5. doi: 10.3201/eid2010.14028825279543
34. Report exposes Syria refugee camp conditions. Al Jazeera. 2013 Aug 5; http://www.aljazeera.com/news/middleeast/2013/08/20138520329121269.html
35. UNHCR. UNHCR study shows rapid deterioration in living conditions of Syrian refugees in Jordan. UNHCR (Internet). 2015 Jan 14; http://www.unhcr.org/54b635b49.html
36. Jones S, Shaheen K, Destitute Syrian refugees in Jordan and Lebanon may return to warzone. The Gaurdian (Internet). 2015Sep11; http://www.theguardian.com/global-development/2015/sep/11/destitute-syrian-refugees-jordan-lebanon-may-return-to-warzone
37. Worldwide displacement hits all-time high as war and persecution increase (Internet). UNHCR. 2015. http://www.unhcr.org/558193896.html
38. Alfred C, What History Can Teach Us About the Worst Refugee Crisis Since WWII (Internet). The Huffington Post. 2015. http://www.huffingtonpost.com/entry/alexander-betts-refugees-wwii_55f30f7ce4b077ca094edaec
39. Hotez PJ, Combating the next lethal epidemic. Science. 2015;348(6232):296–7.
40. Alvar J, Velez I, Bern C, Herrero M, Desjeux P, Cano J, Leishmaniasis worldwide and global estimates of its incedence. PLoS ONE. 2012;7:e35671. doi: 10.1371/journal.pone.003567122693548
41. National reports for the Ministry of Health (Internet). Syrian Arab Republic; 2012 2013. moh.gov.sy
42. McDowell MA, Rafati S, Ramalho-Ortigao M, Salah AB, Leishmaniasis: Middle East and North Africa Research and Development Priorities. PLoS Negl Trop Dis. 2011Jul26;
43. Alawieh A, Musharrafieh U, Jaber A, Berry A, Ghosn N, Bizri AR, Revisiting leishmaniasis in the time of war: the Syrian conflict and the Lebanese outbreak. Int J Infect Dis. 2014;29:115–9. doi: 10.1016/j.ijid.2014.04.02325449245
44. Saab M, El Hage H, Charafeddine K, Habib R, Khalifeh I, Diagnosis of Cutaneous Leishmaniasis: Why Punch When You Can Scrape?Am J Trop Med Hyg. 2015Jan5;93(3):518–22.
45. Hadighi R, Mohebali M, Boucher P, Hajjaran H, Khamesipour A, Ouellette M, Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites. PLoS Med. 2006;3(5):e162. 16605301
46. Hadighi R, Boucher P, Khamesipour A, Meamar A, Roy G, Ouellette M, et al. Glucantime-resistant Leishmania tropica isolated from Iranian patients with cutaneous leishmaniasis are sensitive to alternative antileishmanial drugs. Parasitol Res. 2007;101(5):1319–22. 17610079
47. Gurgen J, Hogan D, Miller R, Chronic cutaneous leishmaniasis infection caused by Leishmania tropica: Resitant to tradional sodium stibogluconate. J Am Acad Dermatol. 2009Mar;60(3):AB54.
48. Al-Salem W, Ferreira D, Dyer N, Alyamani E, Balghonaim S, Al-Mehna A, et al. Detection of high levels of anti-alpha-galactosyl antibodies in sera of patients with Old World cutaneous leishmaniasis: a possible tool for diagnosis and biomarker for cure in an elimination setting. Parasitology. 2014;1–6.
49. Kocarslan S, Turan E, Ekinci T, Yesilova Y, Apari R, Clinical and histopathological characteristics of cutaneous Leishmaniasis in Sanliurfa City of Turkey including Syrian refugees. Indian J Pathol Microniol. 2013;56(3):211–5.
50. Pavlidakey P, Huynh T, McKay K, Sami N, Leishmaniasis Panamensis Masquerading as Myiasis and Sporotrichosis: A Clinical Pitfall. Case Rep Pathol. 2015;949670. doi: 10.1155/2015/94967026413365
51. Croft A, Lestringant G, Baker B, Cutaneous Leishmaniasis following military deployment to Iraq. Med Trop Mars. 2008Apr;66(2):185–8.
52. Ahmad K, War and gerbils compound Afghan leishmaniasis epidemic. Lancet Infect Dis. 2002;2(5):368.
53. Rowland M, Munir A, Durrani N, Noyes H, Reyburn H, An outbreak of cutaneous leishmaniasis in an Afghan refugee settlement in north-west Pakistan. Trans R Soc Trop Med Hyg. 1999Apr;93(2):133–6. 10450434
54. The State of the War Against ISIS: A visual guide to the rise of the Islamic State. The New York Times. 2015Oct22;
55. Aoun K, Bouratbine A, Cutaneous Leishmaniasis in North Africa: a review. Parasite. 2014;21:14. doi: 10.1051/parasite/201401424626301
56. Belal U, Abdel-Hafeez E, Naoi K, Norose K, Cutaneous leishmaniasis in the Nalut District, Libyan Arab Jamahiriya: a clinico-epidemiologic study and Leishmania species identification. J Parasitol. 2012;98(6):1251–6. doi: 10.1645/GE-3086.122551502
57. Mondragon-Shem K, Al-Salem W, Kelly-Hope L, Abdeladhim M, Al-Zahrani M, Valenzuela J, et al. Severity of old world cutaneous leishmaniasis is influenced by previous exposure to sandfly bites in saudi arabia. PLoS Negl Trop Dis. 2015;9(2):e0003449. doi: 10.1371/journal.pntd.000344925646796
58. Fathy F, Al-Kasah F, El-Ahwal A, Emerging cutaneous leishmaniasis in Sirte-Libya: epidemiology, recognition and management. J Egypt Soc Parasitol. 2009;39(3):881–905. 20120753
59. UNHCR. 2015 UNHCR subregional operations profile—North Africa (Internet). http://www.unhcr.org/pages/49e485f36.html
60. Dourgnon P, Kassar H, Refugees in and out North Africa: a study of Choucha refugee camp in Tunisia. Eur J Public Health. 2014;1:6–10.
61. Al-Kamel MA. Regional Leishmaniasis Control Center (RLCC), Yemen (Internet). http://www.rlccye.org/#
62. Khatri M, Di Muccio T, Gramiccia M, Cutaneous leishmaniasis in North-Western Yemen: a clinicoepidemiologic study and Leishmania species identification by polymerase chain reaction-restriction fragment length polymorphism analysis. J Am Acad Dermatol. 2009;61(4):e15–21. doi: 10.1016/j.jaad.2009.04.04719695737
63. Mahdy M, Al-Mekhlafi H, Al-Mekhlafi A, Lim Y, Bin Shuaib N, Azazy A, et al. Molecular characterization of Leishmania species isolated from cutaneous leishmaniasis in Yemen. PLoS ONE. 2010;5(9).
64. Khatri M, Haider N, Cutaneous Leishmaniasis in Yemen. Int J Dermatol. 1999;38(8):587–90. 10487447
65. Narang N, Assisting Uncertainty: How Humanitarian Aid can Inadvertently Prolong Civil War. Int Stud Q. 2015Mar;59(1):184–95.
66. Centers for Disease Control and Prevention. Parasites- Leishmaniasis (Internet). Centers for Disease Control and Prevention. 2015. http://www.cdc.gov/parasites/leishmaniasis/
67. World Health Assembly. Control of Leishmaniasis. World Health Organization; 2007 Mar. Report No.: 12.3.
68. World Health Organization. Media Centre: Leishmaniasis (Internet). World Health Organization. 2015. http://www.who.int/mediacentre/factsheets/fs375/en/
69. Gonzalez U, Pinart M, Sinclair D, Firooz A, Enk C, Velez I, et al. Vector and reservoir control for preventing leishmaniasis. Cochrane Database Syst Rev. 5(8):CD008736.
70. Bezuneh A, Mukhtar M, Abdoun A, Teferi T, Takele Y, Diro E, et al. Comparison of point-of-care tests for the rapid diagnosis of visceral leishmaniasis in East African patients. Am J Trop Med Hyg. 2014Oct13;91(6):1109–15. doi: 10.4269/ajtmh.13-075925311696
71. Oliveira F, Rowton E, Aslan H, Gomes regis, Castrovinci PA, et al. A sand fly salivary protein vaccine shows efficacy against vector-transmitted cutaneous leishmaniasis in nonhuman primates. Sci Transl Med. 2015Jne;7(290):290.
72. Bacon K, Hotez PJ, Kruchten S, Kamhawi S, Bottazzi M, Valenzuela J, et al. The potential economic value of a cutaneous leishmaniasis vaccine in seven endemic countries in the Americas. Vaccine. 2013Jan7;31(3):480–6. doi: 10.1016/j.vaccine.2012.11.03223176979
73. Lee B, Bacon K, Shah M, Kitchen S, Connor D, Slayron R, The economic value of a visceral leishmaniasis vaccine in Bihar state, India. Am J Trop Med Hyg. 2012Mar;86(3):417–25. doi: 10.4269/ajtmh.2012.10-041522403311
74. Morals N, Ahmad MM, NGO-led Microfinance: Potentials and Challenges in Conflict Areas. J Int Dev. 2011Jul;23(5):629–40.
75. Postigo J, Leishmaniasis in the World Health Organization Eastern Mediterranean Region. J Antimicrob Agents. 2010Nov;36(1):S62–5.